BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30776674)

  • 1. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
    Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
    Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells derived from a patient with familial idiopathic basal ganglia calcification (IBGC) caused by a mutation in SLC20A2 gene.
    Sekine SI; Kondo T; Murakami N; Imamura K; Enami T; Shibukawa R; Tsukita K; Funayama M; Inden M; Kurita H; Hozumi I; Inoue H
    Stem Cell Res; 2017 Oct; 24():40-43. PubMed ID: 29034894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC20A2 variants cause dysfunctional phosphate transport activity in endothelial cells induced from Idiopathic Basal Ganglia Calcification patients-derived iPSCs.
    Sekine SI; Nishii K; Masaka T; Kurita H; Inden M; Hozumi I
    Biochem Biophys Res Commun; 2019 Mar; 510(2):303-308. PubMed ID: 30704756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of gene expression pattern and neuroanatomical correlates for SLC20A2 (PiT-2) shows a molecular network with potential impact in idiopathic basal ganglia calcification ("Fahr's disease").
    da Silva RJ; Pereira IC; Oliveira JR
    J Mol Neurosci; 2013 Jun; 50(2):280-3. PubMed ID: 23576097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fahr's disease linked to a novel SLC20A2 gene mutation manifesting with dynamic aphasia.
    Brighina L; Saracchi E; Ferri F; Gagliardi M; Tarantino P; Morzenti S; Musarra M; Patassini M; Annesi G; Ferrarese C
    Neurodegener Dis; 2014; 14(3):133-8. PubMed ID: 25348593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial idiopathic basal ganglia calcification: Histopathologic features of an autopsied patient with an SLC20A2 mutation.
    Kimura T; Miura T; Aoki K; Saito S; Hondo H; Konno T; Uchiyama A; Ikeuchi T; Takahashi H; Kakita A
    Neuropathology; 2016 Aug; 36(4):365-71. PubMed ID: 26635128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and therapeutic potential of sodium-dependent phosphate cotransporters in relation to idiopathic basal ganglia calcification.
    Inden M; Kurita H; Hozumi I
    J Pharmacol Sci; 2022 Jan; 148(1):152-155. PubMed ID: 34924120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of function of Slc20a2 associated with familial idiopathic Basal Ganglia calcification in humans causes brain calcifications in mice.
    Jensen N; Schrøder HD; Hejbøl EK; Füchtbauer EM; de Oliveira JR; Pedersen L
    J Mol Neurosci; 2013 Nov; 51(3):994-9. PubMed ID: 23934451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cell line (ZZUi0014-A) from a patient with spinocerebellar ataxia type 3.
    Wang Y; Sun H; Wang Z; Yue Y; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2019 Dec; 41():101564. PubMed ID: 31639609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1).
    Hozumi I; Kurita H; Ozawa K; Furuta N; Inden M; Sekine SI; Yamada M; Hayashi Y; Kimura A; Inuzuka T; Seishima M
    J Neurol Sci; 2018 May; 388():150-154. PubMed ID: 29627011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new SLC20A2 mutation identified in southern Italy family with primary familial brain calcification.
    Gagliardi M; Morelli M; Annesi G; Nicoletti G; Perrotta P; Pustorino G; Iannello G; Tarantino P; Gambardella A; Quattrone A
    Gene; 2015 Aug; 568(1):109-11. PubMed ID: 25958344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.
    Hsu SC; Sears RL; Lemos RR; Quintáns B; Huang A; Spiteri E; Nevarez L; Mamah C; Zatz M; Pierce KD; Fullerton JM; Adair JC; Berner JE; Bower M; Brodaty H; Carmona O; Dobricić V; Fogel BL; García-Estevez D; Goldman J; Goudreau JL; Hopfer S; Janković M; Jaumà S; Jen JC; Kirdlarp S; Klepper J; Kostić V; Lang AE; Linglart A; Maisenbacher MK; Manyam BV; Mazzoni P; Miedzybrodzka Z; Mitarnun W; Mitchell PB; Mueller J; Novaković I; Paucar M; Paulson H; Simpson SA; Svenningsson P; Tuite P; Vitek J; Wetchaphanphesat S; Williams C; Yang M; Schofield PR; de Oliveira JR; Sobrido MJ; Geschwind DH; Coppola G
    Neurogenetics; 2013 Feb; 14(1):11-22. PubMed ID: 23334463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification.
    Rubino E; Giorgio E; Godani M; Grosso E; Zibetti M; Lopiano L; Ferrero P; Duca S; Moretti L; Gallone S; Rainero I; Brusco A
    J Neurol Sci; 2017 Jun; 377():62-64. PubMed ID: 28477710
    [No Abstract]   [Full Text] [Related]  

  • 15. Slc20a2 is critical for maintaining a physiologic inorganic phosphate level in cerebrospinal fluid.
    Jensen N; Autzen JK; Pedersen L
    Neurogenetics; 2016 Apr; 17(2):125-30. PubMed ID: 26660102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary familial brain calcification with a novel SLC20A2 mutation: Analysis of PiT-2 expression and localization.
    Taglia I; Formichi P; Battisti C; Peppoloni G; Barghigiani M; Tessa A; Federico A
    J Cell Physiol; 2018 Mar; 233(3):2324-2331. PubMed ID: 28722801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological co-occurrence of Fahr's disease and dementia with Lewy bodies.
    Jensen MP; Spasic-Boskovic O; Rowe JB; Galton C; Allinson KSJ
    Clin Neuropathol; 2020; 39(5):227-231. PubMed ID: 32145757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification.
    Nicolas G; Pottier C; Charbonnier C; Guyant-Maréchal L; Le Ber I; Pariente J; Labauge P; Ayrignac X; Defebvre L; Maltête D; Martinaud O; Lefaucheur R; Guillin O; Wallon D; Chaumette B; Rondepierre P; Derache N; Fromager G; Schaeffer S; Krystkowiak P; Verny C; Jurici S; Sauvée M; Vérin M; Lebouvier T; Rouaud O; Thauvin-Robinet C; Rousseau S; Rovelet-Lecrux A; Frebourg T; Campion D; Hannequin D;
    Brain; 2013 Nov; 136(Pt 11):3395-407. PubMed ID: 24065723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification.
    Chen WJ; Yao XP; Zhang QJ; Ni W; He J; Li HF; Liu XY; Zhao GX; Murong SX; Wang N; Wu ZY
    Gene; 2013 Oct; 529(1):159-62. PubMed ID: 23939468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features.
    Donzuso G; Mostile G; Nicoletti A; Zappia M
    Neurol Sci; 2019 Nov; 40(11):2251-2263. PubMed ID: 31267306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.